NCT00976170 Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) Status COMPLETED Phase PHASE1
NCT00971126 Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC) Status TERMINATED Phase PHASE1/PHASE2
NCT00963612 Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI) Status COMPLETED Phase NA
NCT00960518 TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase PHASE2
NCT00960167 A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC) Status UNKNOWN Phase PHASE1
NCT00946153 Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE1/PHASE2
NCT00945568 Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life Status COMPLETED Phase NA
NCT00943449 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00933816 Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT00923897 Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4) Status COMPLETED Phase PHASE2
NCT00921531 Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE3
NCT00914355 Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2) Status COMPLETED Phase PHASE2
NCT00911196 Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT00910572 Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00908752 Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC Status COMPLETED Phase PHASE3
NCT00906984 TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma Status APPROVED_FOR_MARKETING Phase N/A
NCT00906373 A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver Status COMPLETED Phase PHASE2